These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 8943786

  • 1. Metabolic effects of 12-month percutaneous dehydroepiandrosterone replacement therapy in postmenopausal women.
    Diamond P, Cusan L, Gomez JL, Bélanger A, Labrie F.
    J Endocrinol; 1996 Sep; 150 Suppl():S43-50. PubMed ID: 8943786
    [Abstract] [Full Text] [Related]

  • 2. Six-month oral dehydroepiandrosterone supplementation in early and late postmenopause.
    Stomati M, Monteleone P, Casarosa E, Quirici B, Puccetti S, Bernardi F, Genazzani AD, Rovati L, Luisi M, Genazzani AR.
    Gynecol Endocrinol; 2000 Oct; 14(5):342-63. PubMed ID: 11109974
    [Abstract] [Full Text] [Related]

  • 3. Dehydroepiandrosterone (DHEA) replacement reduces growth hormone (GH) dose requirement in female hypopituitary patients on GH replacement.
    Brooke AM, Kalingag LA, Miraki-Moud F, Camacho-Hübner C, Maher KT, Walker DM, Hinson JP, Monson JP.
    Clin Endocrinol (Oxf); 2006 Nov; 65(5):673-80. PubMed ID: 17054472
    [Abstract] [Full Text] [Related]

  • 4. The effects of GH replacement therapy on cardiac morphology and function, exercise capacity and serum lipids in elderly patients with GH deficiency.
    Elgzyri T, Castenfors J, Hägg E, Backman C, Thorén M, Bramnert M.
    Clin Endocrinol (Oxf); 2004 Jul; 61(1):113-22. PubMed ID: 15212653
    [Abstract] [Full Text] [Related]

  • 5. Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age.
    Morales AJ, Nolan JJ, Nelson JC, Yen SS.
    J Clin Endocrinol Metab; 1994 Jun; 78(6):1360-7. PubMed ID: 7515387
    [Abstract] [Full Text] [Related]

  • 6. Serum homocysteine concentrations in children with growth hormone (GH) deficiency before and after 12 months GH replacement.
    Esposito V, Di Biase S, Lettiero T, Labella D, Simeone R, Salerno M.
    Clin Endocrinol (Oxf); 2004 Nov; 61(5):607-11. PubMed ID: 15521964
    [Abstract] [Full Text] [Related]

  • 7. The association of androgenic sex steroids with serum lipid levels in postmenopausal women.
    Noyan V, Yucel A, Sagsoz N.
    Acta Obstet Gynecol Scand; 2004 May; 83(5):487-90. PubMed ID: 15059164
    [Abstract] [Full Text] [Related]

  • 8. Effects of dehydroepiandrosterone supplement on health-related quality of life in glucocorticoid treated female patients with systemic lupus erythematosus.
    Nordmark G, Bengtsson C, Larsson A, Karlsson FA, Sturfelt G, Rönnblom L.
    Autoimmunity; 2005 Nov; 38(7):531-40. PubMed ID: 16373258
    [Abstract] [Full Text] [Related]

  • 9. Dehydroepiandrosterone supplementation in women with adrenal failure: impact on twenty-four hour GH secretion and IGF-related parameters.
    Christiansen JJ, Gravholt CH, Fisker S, Svenstrup B, Bennett P, Veldhuis J, Andersen M, Christiansen JS, Jørgensen JO.
    Clin Endocrinol (Oxf); 2004 Apr; 60(4):461-9. PubMed ID: 15049961
    [Abstract] [Full Text] [Related]

  • 10. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
    Petersen KR.
    Dan Med Bull; 2002 Feb; 49(1):43-60. PubMed ID: 11894723
    [Abstract] [Full Text] [Related]

  • 11. The association of dehydroepiandrosterone, obesity, waist-hip ratio and insulin resistance with fatty liver in postmenopausal women--a hyperinsulinemic euglycemic insulin clamp study.
    Saruç M, Yüceyar H, Ayhan S, Türkel N, Tuzcuoglu I, Can M.
    Hepatogastroenterology; 2003 Feb; 50(51):771-4. PubMed ID: 12828082
    [Abstract] [Full Text] [Related]

  • 12. [Role of the steroids, SHBG, IGF-1, IGF BP-3 and growth hormone in glucose metabolism disorders during long-term treatment with low doses of glucocorticoids].
    Vondra K, Hampl R, Nĕmcová D, Hill M, Hoza J, Kot'átková A, Stárka L, Vrbíková J, Zamrazil V.
    Cas Lek Cesk; 2002 Feb 15; 141(3):89-95. PubMed ID: 11925670
    [Abstract] [Full Text] [Related]

  • 13. Regional body fat distribution and metabolic profile in postmenopausal women.
    Piché ME, Lapointe A, Weisnagel SJ, Corneau L, Nadeau A, Bergeron J, Lemieux S.
    Metabolism; 2008 Aug 15; 57(8):1101-7. PubMed ID: 18640388
    [Abstract] [Full Text] [Related]

  • 14. Effects of estrogen replacement therapy on abdominal fat compartments as related to glucose and lipid metabolism in early postmenopausal women.
    Mattiasson I, Rendell M, Törnquist C, Jeppsson S, Hulthén UL.
    Horm Metab Res; 2002 Oct 15; 34(10):583-8. PubMed ID: 12439787
    [Abstract] [Full Text] [Related]

  • 15. Differing effects of low-dose estrogen-progestin therapy and pravastatin in postmenopausal hypercholesterolemic women.
    Davis SR, Goldstat R, Newman A, Berry K, Burger HG, Meredith I, Koch K.
    Climacteric; 2002 Dec 15; 5(4):341-50. PubMed ID: 12626213
    [Abstract] [Full Text] [Related]

  • 16. Adiponectin is involved in the protective effect of DHEA against metabolic risk in aged rats.
    Pérez-de-Heredia F, Sánchez J, Priego T, Nicolás F, Portillo Mdel P, Palou A, Zamora S, Garaulet M.
    Steroids; 2008 Oct 15; 73(11):1128-36. PubMed ID: 18534650
    [Abstract] [Full Text] [Related]

  • 17. Body fat distribution in pre-and post-menopausal women: metabolic and anthropometric variables.
    Garaulet M, Pérez-Llamas F, Baraza JC, Garcia-Prieto MD, Fardy PS, Tébar FJ, Zamora S.
    J Nutr Health Aging; 2002 Oct 15; 6(2):123-6. PubMed ID: 12166365
    [Abstract] [Full Text] [Related]

  • 18. Is there a threshold of visceral fat loss that improves the metabolic profile in obese postmenopausal women?
    Brochu M, Tchernof A, Turner AN, Ades PA, Poehlman ET.
    Metabolism; 2003 May 15; 52(5):599-604. PubMed ID: 12759890
    [Abstract] [Full Text] [Related]

  • 19. Effect of short-term therapy with recombinant human growth hormone (GH) on metabolic parameters and preclinical atherosclerotic markers in hypopituitary patients with growth hormone deficiency.
    Benedini S, Dalle Carbonare L, Albiger N, Scanarini M, Bilora F, Petrobelli F, Giannini S, Mantero F, Scaroni C.
    Horm Metab Res; 2006 Jan 15; 38(1):16-21. PubMed ID: 16477535
    [Abstract] [Full Text] [Related]

  • 20. Effects of postmenopausal hormone replacement therapy on body fat composition.
    Yüksel H, Odabasi AR, Demircan S, Köseoğlu K, Kizilkaya K, Onur E.
    Gynecol Endocrinol; 2007 Feb 15; 23(2):99-104. PubMed ID: 17454160
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.